Lee JB, Litzner BR, Vidal CI. Review of the current medical literature and assessment of current utilization patterns regarding mismatch repair protein immunohistochemistry in cutaneous Muir-Torre syndrome-associated neoplasms. J Cutan Pathol. 2017;44:931–7.

Article  Google Scholar 

Shalin SC, Lyle S, Calonje E, Lazar AJ. Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications. Histopathology. 2010;56:133–47.

Article  Google Scholar 

Coquillard C, Boustany A, DeCoster RC, Vasconez HC. Muir-Torre syndrome presenting as a sebaceous carcinoma of the Nasal Ala. Am Surg. 2019;85:e115–7.

Article  Google Scholar 

Eiger-Moscovich M, Eagle RC Jr, Shields CL, Racher H, Lally SE, Silkiss RZ, et al. Muir-Torre syndrome associated periocular sebaceous neoplasms: screening patterns in the literature and in clinical practice. Ocular Oncol Pathol. 2020;6:226–37.

Article  Google Scholar 

Simic D, Dummer R, Freiberger SN, Ramelyte E, Barysch MJ. Clinical and Molecular Features of Skin Malignancies in Muir-Torre Syndrome. Genes. 2021;12:781.

Article  CAS  Google Scholar 

Rios CA, Villalón R, Muñoz J, Acuña M, Cifuentes L. Muir-Torre syndrome: case report and molecular characterization. Sao Paulo Med J Revista paulista de medicina. 2014;132:61–4.

Article  Google Scholar 

Wargo JJ, Plaza JA, Carr D. Sebaceous neoplasia leading to the diagnosis of Muir-Torre syndrome in an African American man. JAAD case reports. 2021;11:72–3.

Article  Google Scholar 

John AM, Schwartz RA. Muir-Torre syndrome (MTS): An update and approach to diagnosis and management. J Am Acad Dermatol. 2016;74:558–66.

Article  Google Scholar 

Roberts ME, Riegert-Johnson DL, Thomas BC, Rumilla KM, Thomas CS, Heckman MG, et al. A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir-Torre variant of Lynch syndrome. Genet Med. 2014;16:711–6.

Article  Google Scholar 

Grob A, Feser C, Grekin S. Muir-Torre syndrome: a case associated with an infrequent gene mutation. J Clin Aesthetic Dermatol. 2016;9:56–9.

Google Scholar 

Singh RS, Grayson W, Redston M, Diwan AH, Warneke CL, McKee PH, Lev D, Lyle S, Calonje E, Lazar AJ. Site and tumor type predicts DNA mismatch repair status in cutaneous sebaceous neoplasia. Am J Surg Pathol. 2008;32(6):936–42.

Article  Google Scholar 

Zhang R, Bhate C, Cai D. Genetic heterogeneity in a patient with Muir-Torre syndrome. JAAD case reports. 2020;6:886–91.

Article  Google Scholar 

Marazza G, Masouyé I, Taylor S, Prins C, Gaudin T, Saurat JH, et al. An illustrative case of Muir-Torre syndrome: contribution of immunohistochemical analysis in identifying indicator sebaceous lesions. Arch Dermatol. 2006;142:1039–42.

Article  Google Scholar 

Chen Q, Wang M, Xu Z, Wang M, Jin S, Tian S, et al. Muir-Torre syndrome with a frame-shift mutation in the MSH2 gene: a rare case report and literature review. Int J Gynecol Pathol. 2020;39:136–40.

Article  CAS  Google Scholar 

Mojtahed A, Schrijver I, Ford JM, Longacre TA, Pai RK. A two-antibody mismatch repair protein immunohistochemistry screening approach for colorectal carcinomas, skin sebaceous tumors, and gynecologic tract carcinomas. Mod Pathol. 2011;24:1004–14.

Article  Google Scholar 

Vidal CI, Sutton A, Armbrect EA, Lee JB, Litzner BR, Hurley MY, et al. Muir-Torre syndrome appropriate use criteria: effect of patient age on appropriate use scores. J Cutan Pathol. 2019;46:484–9.

Article  Google Scholar 

Spielvogel RL, DeVillez RL, Roberts LC. Oral isotretinoin therapy for familial Muir-Torre syndrome. J Am Acad Dermatol. 1985;12:475–80.

Article  CAS  Google Scholar 

Ishiguro Y, Homma S, Yoshida T, Ohno Y, Ichikawa N, Kawamura H, et al. Usefulness of PET/CT for early detection of internal malignancies in patients with Muir-Torre syndrome: report of two cases. Surg Case Reps. 2017;3:71.

Article  Google Scholar 

Burris CKH, Rodriguez ME, Raven ML, Reddy DN, Xu YG, Wiggs JL, et al. Muir-Torre syndrome: the importance of a detailed family history. Case Rep Ophthalmol. 2019;10:180–5.

Article  Google Scholar 

Shiki M, Hida T, Sugano K, Kaneko R, Kamiya T, Sakurai A, et al. Muir-Torre syndrome caused by exonic deletion of MLH1 due to homologous recombination. Eur J Dermatol EJD. 2017;27:54–8.

Article  Google Scholar 

Banerjee N, Hossain F, Wirtschafter E, Fathizadeh P. Pembrolizumab in the treatment of microsatellite instability-high sebaceous carcinoma: a case report with review of the literature. JCO Precis Oncol. 2020;4:61–5.

Article  Google Scholar 

Cino D, Drumm C, Sheahan K, D’Arcy C, Nolan N, Hoti E, et al. Muir-Torre syndrome: a case of unusual coexisting genetic mutations. Clin Exp Dermatol. 2022;47:602–4.

Article  CAS  Google Scholar 

Joshi TP, Farr MA, Lewis DJ. Isotretinoin as chemoprophylaxis for cutaneous malignancies in Muir-Torre syndrome: a novel concept. Dermatol Ther. 2022;35: e15540.

Article  CAS  Google Scholar 

Graefe T, Wollina U, Schulz H, Burgdorf W. Muir-Torre syndrome—treatment with isotretinoin and interferon alpha-2a can prevent tumour development. Dermatology (Basel, Switzerland). 2000;200:331–3.

Article  CAS  Google Scholar 

Ponti G, Ponz de Leon M. Muir-Torre syndrome. Lancet Oncol. 2005;6:980–7.

Article  Google Scholar 

Shanks A, Laun J, Holstein A, Varshney S, Messina J, Cruse CW. A rare concurrence of Muir-Torre-associated sebaceous carcinoma in the setting of a lipedematous scalp. Case Rep Plastic Surg hand Surg. 2020;7:124–9.

Article  Google Scholar